Chair Ad InterimMD Anderson Cancer Center, United States
89: Survival Outcomes in Patients with Resectable Gastric Cancer Treated with Total Neoadjuvant Therapy
Friday, March 22, 202410:32am – 10:42am ET
92: Phase I Trial of Short-Course Chemoradiotherapy followed by Chemotherapy as Total Neoadjuvant Therapy for Patients with Potentially Resectable Gastric Cancer
Friday, March 22, 202411:02am – 11:12am ET
